Association of Human Immunoglobulin G1 Heavy Chain Variants With Neutralization Capacity and Antibody-Dependent Cellular Cytotoxicity Against Human Cytomegalovirus
- 27 July 2016
- journal article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 214 (8) , 1175-1179
Abstract
Human Cytomegalovirus (HCMV) infection is limited by HCMV-specific antibody (AB) functions. Here the association between the genetic marker (GM) 3/17 variants in the IgG1 heavy chain constant region, virus neutralization and NK-cell activation was investigated. In 100 HCMV-seropositive individuals the GM3/17 polymorphism, serum 50% HCMV-AB neutralization (NT50) and in vitro HCMV-AB NK-cell activation was assessed. HCMV NT50 was higher in heterozygous GM3/17 than in GM3/3 persons (P=0.0276). Furthermore, individuals expressing GM3/17 exhibited significantly higher NK-cell activation than persons carrying GM3/3 (P<0.0001) or GM17/17 (P=0.0095). Thus, persons expressing GM3/17 have potentially a selective advantage in HCMV-defense.Keywords
Funding Information
- Department of Virology, Medical University of Vienna
This publication has 13 references indexed in Scilit:
- NK Cell and Ig Interplay in Defense against Herpes Simplex Virus Type 1: Epistatic Interaction of CD16A and IgG1 Allotypes of Variable Affinities Modulates Antibody-Dependent Cellular Cytotoxicity and Susceptibility to Clinical ReactivationThe Journal of Immunology, 2015
- The decoy Fcγ receptor encoded by the cytomegalovirus UL119-UL118 gene has differential affinity to IgG proteins expressing different GM allotypesHuman Immunology, 2015
- Natural Killer Cells Can Inhibit the Transmission of Human Cytomegalovirus in Cell Culture by Using Mechanisms from Innate and Adaptive Immune ResponsesJournal of Virology, 2015
- Immunoglobulin Genes Influence the Magnitude of Humoral Immunity to Cytomegalovirus Glycoprotein BThe Journal of Infectious Diseases, 2014
- Human Cytomegalovirus Fcγ Binding Proteins gp34 and gp68 Antagonize Fcγ Receptors I, II and IIIPLOS Pathogens, 2014
- Control of Human Viral Infections by Natural Killer CellsAnnual Review of Immunology, 2013
- IgG1 heavy chain-coding gene polymorphism (G1m allotypes) and development of antibodies-to-infliximabPharmacogenetics and Genomics, 2009
- Immunobiology of Human Cytomegalovirus: from Bench to BedsideClinical Microbiology Reviews, 2009
- Human cytomegalovirus serum neutralizing antibodies block virus infection of endothelial/epithelial cells, but not fibroblasts, early during primary infectionJournal of General Virology, 2008
- HLAand HIV-1: Heterozygote Advantage andB*35-Cw*04DisadvantageScience, 1999